The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...

FutureWise Research, a global leader in healthcare market intelligence, today announced the release of its groundbreaking report titled Colorectal Cancer Liquid Biopsy Market – Global Trends, ...

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with 95% accuracy. The test overcomes the limitations of DNA-based methods.

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

Using blood samples from patients with colorectal cancer, the test was able to detect the earliest stages of the disease with 95% accuracy, vastly improving on current, commercially available, non ...

A new ensemble deep learning model, HIELCC-EDL, accurately identifies lung and colon cancers using histopathological images. This approach significantly improves early diagnosis and patient ...

Chekuri, V. and Trotter, G. (2025) Case Report: A Diagnostic Odyssey Unveiling BCGosis in an Elderly Patient. Case Reports in ...

Blood in the stool may be a sign of cancer in the colon. Biopsy: The health care provider removes cell or tissue samples so they can be viewed under a microscope to check for signs of cancer. Staging ...